Can-Fite BioPharma CANF Cash Flow Statement (2013-2025)

NYSE CANF
$3.42 +0.02 (+0.59%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2013 Mar2014 Jun2014 Sep2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Dec2024 Dec2025
Operating Activities
Net Income (Quarter)
-2.25M-2.10M-4.28M-3.83M-2.58M-4.35M-2.17M-3.13M-3.40M-6.71M-2.37M-2.07M-2.57M-27.70M-2.71M-2.76M-1.86M-28.50M
Share-based Compensation (Quarter)
230.000.30M0.12M0.13M
Non-cash Items (Quarter)
Cash from Operations (Quarter)
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
Additional items
Beginning Cash Balance (Quarter)
3.62M
Exchange Rate Effect (Quarter)
Free Cash Flow (Quarter)
Net Cash Flow (Quarter)